Dr. Acheson, Former Chief Medical Officer for USDA and FDA, will advise the company as it develops advanced testing technology for the food safety industry SCOTTSDALE, Ariz. — PathogenDx, Inc., an Arizona based technology company which has developed a multiplexed microarray DNA-based pathogen testing platform, announced today that Dr. David Acheson will join the company as a strategic advisor. As part […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT®) Sequencing technology. Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have […]
— Complete Gene Offering Improved Efficiency for Customers — SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Dec. 10, 2020– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Clonal-Ready Gene Fragments, providing customers with a complete offering for genes. Twist’s best-in-class Gene […]
BioSkryb’s grant program will support up to two researchers to empower their discoveries through ResolveDNA™, the company’s novel whole genome amplification products that provide unprecedented genome coverage and accuracy ResolveDNA incorporates BioSkryb’s primary template-directed amplification (PTA) technology, which was created to address the inherent challenges of single-cell genomics by producing high-quality gene sequencing data BioSkryb, […]
Dr. Paik’s deep expertise in microfluidics and product development to be applied in advancing Molecular Assemblies’ breakthrough enzymatic DNA synthesis technology into a commercial platform SAN DIEGO — Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced the appointment of Phil Paik, Ph.D., as Vice President, Platform Development. Dr. Paik […]
Building on previous partnership successes, the organizations seek to accelerate time to diagnosis for pediatric patients with genetic diseases SAN DIEGO & WELLESLEY, Mass. — Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has launched an Early Access Program for its whole transcriptome panel using the HTG EdgeSeq technology. The Early Access Program is intended to allow select customers access to the panel […]
To Incorporate Third Generation Sequencing into Clinical In Vitro Diagnostics Platform. Ghent, Belgium – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they have been awarded a 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) to develop a clinical in vitro diagnostics (IVD) platform incorporating third generation sequencing (TGS) technologies. The project, […]
• T-cell response has the potential to give a clearer picture of immunity and course of illness • T-cell response to SARS-CoV-2 may decline less rapidly than antibodies • Potentially vital tool for research into immune response and vaccination efficacy Hilden, Germany and Germantown, Maryland – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today […]
During an update at the 2020 Nanopore Community Meeting, Oxford Nanopore revealed a number of key advances in its sequencing technology. These include the release of new improvements in PromethION flow cells that have enabled a new 10 Terabase sequencing record, modal single-read accuracy of 99.1% using a new sequencing chemistry currently in development, high accuracy variant calling tools and automation options for nanopore sequencing experiments at any scale. Further […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
